Navigation Links
Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands
Date:9/21/2009

MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, announced today that G. Frederick Wilkinson has joined the Company as Executive Vice President, Global Brands. In this newly expanded position Mr. Wilkinson will be responsible for all aspects of the Company's global brand pharmaceutical business, including brand product development, global sales and marketing and coordinating brand product business development activities. In addition, Mr. Wilkinson will oversee Watson's biologic development efforts. Mr. Wilkinson will report directly to Paul Bisaro, President and Chief Executive Officer.

"Fred returns to Watson with an extraordinary record of accomplishments having built a successful brand products business at Duramed Pharmaceuticals, the brand business of Barr Pharmaceuticals, particularly in the area of women's healthcare," said Paul Bisaro, Watson CEO. "We will look to Fred to further strengthen our US brand business, which includes a strong product portfolio supported by the recent launches of RAPAFLO(R) and Gelnique(R)."

"Fred's global experience will also be invaluable as we seek to maximize opportunities for our brand portfolio in new markets that will result from the successful acquisition of Arrow Group, which is expected to close this fall," Bisaro added. "Finally, Fred's experience in biologics, including expansion of Barr's biopharmaceutical production capabilities, development of a pipeline of early stage projects, and his work to shepherd Barr's initial biologics vaccine product through the FDA clinical development process, will enable him to effectively guide our efforts in becoming a leader in the generic biologics area."

Most recently
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... The plastic surgery ... on the cosmetic surgery industry with its commitment, teamwork, and dedication — all ... medical provider is committed to patient safety, world-class results, and compassionate care. With ...
(Date:7/7/2015)... ... 07, 2015 , ... Dermatologists from the Mount Sinai Health ... 18 possible melanomas and 46 potential non-melanoma skin cancers (basal cell and squamous ... Aspen Ideas Festival, which was held from June 25 through July 4, 2015, ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June ... rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by the ... youthful than she has in some time and speculate that she might have ...
(Date:7/7/2015)... ... 07, 2015 , ... Celestix Networks, the leading provider of ... Series virtual appliances. These virtual platforms expand the existing physical appliances under ... to simplify the on-premises deployment of unified remote access and single sign-on (SSO). ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... Inc. to access its antibody combination therapy (ACT) technology platform. The platform ...
Breaking Medicine News(10 mins):Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2
... , ... medical founder of Minute Clinic, joins Consult A Doctor, Inc. as Chief Medical Officer; calls ... , ... 13, 2010 -- Consult A Doctor, Inc . announced today that Douglas Smith, board-certified ...
... ... Journal of Otology and Neurotology a “Letter to the Editor” documenting the improvement for ... Prosthesis Syndrome” focuses on two recent cases that were referred to Dr. Lippy, following ... ...
... ... ... Music announces the April 13, 2010 release of , in my room , -a ... and produced by LML recording artist D.C. Anderson , the prolific writer/producer/performer behind the ...
... ... mobile networks will rise to almost $1.9 billion globally by 2014, with heart based monitoring ... ... According to Juniper Research, revenues from remote patient monitoring using mobile networks will rise to ...
... ... , ... (Vocus) April 13, 2010 -- Susan Z. Robins, President of Muscle Angels™, launched ... The response was overwhelmingly positive and Muscle Angel Massagers™ were awarded a “Top ...
... , HOUSTON - The molecular machinery that switches on a ... other organs has been identified by an international team led ... Cancer Center. The paper was published Sunday in Nature ... a target-rich environment for development of drugs to thwart expression ...
Cached Medicine News:Health News:Consult A Doctor, Inc. Names Retail Clinic Pioneer, Douglas Smith, M.D. as Chief Medical Officer 2Health News:Consult A Doctor, Inc. Names Retail Clinic Pioneer, Douglas Smith, M.D. as Chief Medical Officer 3Health News:New Study Identifies Cause of Severe Disequilibrium and Significant Memory Loss Following Stapedectomy Surgery 2Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 2Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 3Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 4Health News:Revenues from Mobile Health Monitoring to Reach $1.9 Billion Globally by 2014 Says Juniper Research 2Health News:Revenues from Mobile Health Monitoring to Reach $1.9 Billion Globally by 2014 Says Juniper Research 3Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 2Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 3Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 4Health News:Muscle Angel Massagers™ Receive Accolades from Dentists and Hygienists 5Health News:Scientists find key to gene that promotes cancer metastasis 2
(Date:7/7/2015)... International Corporation (NASDAQ: PRXL ) will release financial results ... August 5 th , 2015 after the close of the ... at www.PAREXEL.com and on the PRNewswire website at ... call and live webcast at 10:00 a.m. EDT on Thursday, ... access the webcast, visit PAREXEL,s website at www.PAREXEL.com , ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, ... "Company"), a leader in embolic protection systems ("EPS"), ... Embolic Protection System integrated with MicroNet ™ ... Coronary Stent New Product Innovation Award.  Through active ... of analysts and consultants recognize the successful introduction ...
(Date:7/7/2015)... Minn. , July 7, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... of its previously announced public offering of 32,000,000 units. Each ... one Series A warrant to purchase one share of ... unit. Investors whose purchase of units in the offering ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... June 08, 2007 /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today ... research project with scientists at Fox,Chase Cancer Center ... Lexicon researchers have discovered a novel and,surprising role ... T lymphocytes. These findings have been published in,the ...
... - NuPathe Inc., a,privately held specialty pharmaceutical ... Phase I study of NP101,SmartRelief, a novel ... NP101 combines NuPathe's SmartRelief(TM) proprietary,iontophoretic transdermal technology ... acute migraine in the United,States. Sumatriptan is ...
Cached Medicine Technology:Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
... The ThromCat™ System is the first thrombectomy ... strength and simplicity for the full range ... Heliflex™ technology, the new ThromCat™ System flushes, ... of 700 mmHg and incorporates advanced vessel-wall ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
... patented telescoping plate design integrates ... plate and vertebral column spacer. ... the need for supplemental fixation ... of bone graft to be ...
Medicine Products: